Skip to content
healthcare.dev

ATOVAQUONE

NDC 70748-299, ATOVAQUONE, suspension, from Lupin Pharmaceuticals, Inc..

Product NDC
70748-299
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210692
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70748-299 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOVAQUONE750 mg/5mL

Pharmacologic classes

Antimalarial [EPC]; Antiprotozoal [EPC]

Package NDCNDC-11Package
70748-299-01707480299011 BOTTLE in 1 CARTON (70748-299-01) / 210 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/03ddcc33-729c-4d46-ae6b-2ee47978ba16

Use it

Look up 70748-299 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70748-299 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70748-299. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.